ロード中...
Immunosuppression in inflammatory bowel disease: how much is too much?
PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....
保存先:
| 出版年: | Curr Opin Gastroenterol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/ https://ncbi.nlm.nih.gov/pubmed/22573191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|